|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ATRA | Dupont Jakob | EVP, Head of R&D | Mar 02 '23 | Sale | 3.63 | 5,074 | 18,403 | 290,794 | Mar 06 06:46 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Nov 16 '22 | Sale | 4.49 | 4,342 | 19,497 | 154,540 | Nov 18 08:13 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Aug 16 '22 | Sale | 5.03 | 4,124 | 20,760 | 158,882 | Aug 18 06:21 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | May 17 '22 | Sale | 5.32 | 3,873 | 20,597 | 163,006 | May 19 05:08 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Mar 01 '22 | Sale | 9.86 | 2,221 | 21,890 | 166,879 | Mar 03 07:02 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Feb 10 '22 | Option Exercise | 9.58 | 5,000 | 47,900 | 95,594 | Feb 14 05:42 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Feb 10 '22 | Sale | 16.00 | 5,000 | 80,000 | 90,594 | Feb 14 05:42 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Jan 03 '22 | Option Exercise | 9.58 | 5,000 | 47,900 | 95,594 | Jan 05 04:47 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Jan 03 '22 | Sale | 16.01 | 5,000 | 80,050 | 90,594 | Jan 05 04:47 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Dec 01 '21 | Option Exercise | 9.58 | 5,000 | 47,900 | 95,594 | Dec 03 04:15 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Dec 01 '21 | Sale | 17.94 | 5,000 | 89,688 | 90,594 | Dec 03 04:15 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Nov 16 '21 | Sale | 17.12 | 2,199 | 37,640 | 90,594 | Nov 18 05:52 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Nov 02 '21 | Option Exercise | 9.58 | 5,000 | 47,900 | 97,793 | Nov 04 04:10 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Nov 02 '21 | Sale | 16.41 | 5,000 | 82,050 | 92,793 | Nov 04 04:10 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | Aug 17 '21 | Sale | 12.53 | 2,152 | 26,969 | 92,793 | Aug 19 07:32 PM |
| ATRA | Dupont Jakob | EVP, Head of R&D | May 18 '21 | Sale | 14.55 | 5,184 | 75,427 | 94,945 | May 20 04:32 PM |
| GOSS | Dupont Jakob | Chief Medical Officer | Dec 27 '19 | Option Exercise | 10.71 | 1,994 | 21,356 | 1,994 | Dec 31 05:00 PM |
| GOSS | Dupont Jakob | Chief Medical Officer | Dec 30 '19 | Option Exercise | 10.71 | 40,000 | 428,400 | 40,000 | Dec 31 05:00 PM |
| GOSS | Dupont Jakob | Chief Medical Officer | Dec 30 '19 | Sale | 15.00 | 40,000 | 600,004 | 0 | Dec 31 05:00 PM |
| GOSS | Dupont Jakob | Chief Medical Officer | Dec 27 '19 | Sale | 15.81 | 1,994 | 31,534 | 0 | Dec 31 05:00 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite